Journal
MOLECULAR AND CELLULAR BIOLOGY
Volume 23, Issue 20, Pages 7222-7229Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/MCB.23.20.7222-7229.2003
Keywords
-
Categories
Funding
- NIDDK NIH HHS [R37DK31405, K08 DK002885, R03 DK58850, KO8 DK02885, R01 DK33201, KO8 DK02535, R37 DK031405, R01 DK033201] Funding Source: Medline
Ask authors/readers for more resources
The nuclear hormone receptor peroxisome proliferator-activated receptor gamma (PPARgamma) is an important regulator of lipid and glucose homeostasis and cellular differentiation. Studies of many cell types in vitro and in vivo have demonstrated that activation of PPARgamma can reduce cellular proliferation. We show here that activation of PPARgamma is sufficient to reduce the proliferation of cultured insulinoma cell lines. We created a model with mice in which the expression of the PPARG gene in beta cells was eliminated (betagammaKO mice), and these mice were found to have significant islet hyperplasia on a chow diet. Interestingly, the normal expansion of beta-cell mass that occurs in control mice in response to high-fat feeding is markedly blunted in these animals. Despite this alteration in beta-cell mass, no effect on glucose homeostasis in betagammaKO mice was noted. Additionally, while thiazolidinediones enhanced insulin secretion from cultured wild-type islets, administration of rosiglitazone to insulin-resistant control and betagammaKO mice revealed that PPARgamma in beta cells is not required for the antidiabetic actions of these compounds. These data demonstrate a critical physiological role for PPARgamma function in beta-cell proliferation and also indicate that the mechanisms controlling beta-cell hyperplasia in obesity are different from those that regulate baseline cell mass in the islet.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available